Skip to content
Search

Latest Stories

Pharmacist Support's 2023 impact report highlights enhanced digital access and wellbeing advancements

Pharmacist Support's 2023 impact report highlights enhanced digital access and wellbeing advancements
Pharmacist Support's latest report underscores increased spending on counseling, addiction support, and grants, alongside celebrating key milestones in their support for the pharmacy community

Pharmacist Support has released its 2023 Impact Report, revealing significant growth in digital access and well-being initiatives.

The report shows a 49 per cent increase in website visits and a corresponding 47 per cent rise in pages viewed compared to the previous year.


These improvements reflect the charity's investment in digital infrastructure to enhance access to critical services for pharmacists nationwide.

Additionally, calls to the peer support scheme, Listening Friends, increased by 74 per cent , aided by the introduction of an online referral form.

The charity also reported a 23 per cent rise in financial grants awarded, amounting to £193,528, through a new online grants portal.

Esther Sadler-Williams, Chair of Pharmacist Support, highlighted the impact of these advancements, stating:

"This past year has shown the impact our investment in digital has had, enabling easier access to support, information, and advice, helping more individuals, whilst enabling our charity team to manage demand."

Pharmacist Support also expanded its wellbeing initiatives in 2023, including the launch of the 'Embracing a Workplace Wellbeing Culture' online course.

Moreover, they charity garnered increased participation in its ACTNow campaigns aimed at promoting mental health awareness among pharmacy professionals.

The campaign saw a total of 29 per cent growth in sign-ups across the three campaigns targeted at students, trainees, and pharmacists.

"We were also delighted to increase our pool of volunteers," added Sadler-Williams “focusing particularly on student ambassadors to help us improve awareness of our services and support to those at the beginning of their pharmacy journey."

"Alongside the growth in Listening Friends support, the number of volunteer hours recorded in 2023 grew by 70 per cent compared to 2022," she added.

Expressing gratitude to key partners, Esther Sadler- Williams emphasised the pivotal role of donations from charity partners such as the PDA and Teva UK.

She stated, “The donations of our charity partners, the PDA and Teva UK, enabled us to further our mission to support the wellbeing of our pharmacy family."

"Other support from organisations such as Boots, Locate a Locum, Clinical Pharmacy Congress, RPS, BPSA, CPPE and the Pharmacy Show helped us to develop our campaign activities and enabled us to reach many more individuals.”

She also acknowledged the increased expenditure on counseling, addiction support, and grants compared to initial plans.

She noted, “Although we have spent more on counselling, addiction support, and grants than we had planned, the Board was pleased to continue to facilitate support where it is most needed."

"However, rising inflation has been a challenge, and coupled with the increased demand for our services, we will continue to work to increase donations in order that we can exist for our beneficiaries in perpetuity.”

Sadler-Williams expressed pride in Pharmacist Support’s achievements over the past year, highlighting feedback from service users and industry recognition.

She remarked, “We are extremely proud of the help we have been able to offer over the past twelve months.

"With 100 per cent of service users saying they would come back to us again if they needed further advice or support in the future, and recognition from our colleagues in the charitable sector in the form of the ‘ACO Small Charity of the Year’ Award, it really brought home to us just what we have been able to achieve.”

Looking ahead, Pharmacist Support remains focused on advocating for sustainable funding to meet the growing demand and continue supporting pharmacists across the UK.

More For You

NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
AAH upgrades ordering portal, making procurement easier for pharmacies

AAH Cascade compares prices and availability across suppliers

AAH Warehouse

AAH upgrades ordering portal to improve product visibility

Leading pharmaceutical wholesaler AAH Pharmaceuticals Ltd has introduced new digital functionalities to AAH Cascade, its independently managed ordering portal, making procurement easier and more cost-effective for pharmacies.

AAH Cascade compares product prices and availability across multiple suppliers, eliminating the need for manual searches.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less